Optic neuritis post-COVID-19 infection. A case report with meta-analysis.
COVID-19
Optic neuritis
Journal
Interdisciplinary neurosurgery : Advanced techniques and case management
ISSN: 2214-7519
Titre abrégé: Interdiscip Neurosurg
Pays: Netherlands
ID NLM: 101648481
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
29
03
2021
revised:
13
06
2021
accepted:
18
07
2021
entrez:
27
7
2021
pubmed:
28
7
2021
medline:
28
7
2021
Statut:
ppublish
Résumé
In December 2019, a global pandemic of Coronavirus 2019 (COVID-19) has invaded entire the world. The virus associated with the COVID-19 infections is SARS-CoV-2; the infections are mainly pulmonary manifesting as severe respiratory complications such as acute respiratory distress syndrome. However, there are some extra-pulmonary manifestations that are reported to be associated with SARS-CoV-2 from the published literature. We aim to report a case manifested as post-COVID-19 optic neuritis, in addition to make a quantitative analysis (meta-analysis) for the published similar case reports around the world. We followed CARE guidelines for case reports. Also, we followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A 32-year-old male patient with no previous relevant medical history, presented to the ophthalmology clinic in a tertiary hospital. He complained of a sudden drop of vision in his left eye, throbbing left sided headaches, central scotoma, color depth affection, elevated intra-ocular pressure; two weeks post-COVID-19 infection. Post-COVID optic neuritis is a possible neurological complication of the novel coronavirus infection. It was shown that females were more affected by optic neuritis and retinal complications, the left eye is more liable to drop of visual acuity post-COVID-19 infection; while there was no significant difference between both eyes regarding accompanied vision loss or blindness. Optic neuritis either unilateral or bilateral could be one of the possible viral manifestations after COVID-19 infection.
Sections du résumé
BACKGROUND
BACKGROUND
In December 2019, a global pandemic of Coronavirus 2019 (COVID-19) has invaded entire the world. The virus associated with the COVID-19 infections is SARS-CoV-2; the infections are mainly pulmonary manifesting as severe respiratory complications such as acute respiratory distress syndrome. However, there are some extra-pulmonary manifestations that are reported to be associated with SARS-CoV-2 from the published literature. We aim to report a case manifested as post-COVID-19 optic neuritis, in addition to make a quantitative analysis (meta-analysis) for the published similar case reports around the world.
METHODS
METHODS
We followed CARE guidelines for case reports. Also, we followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
CASE PRESENTATION
METHODS
A 32-year-old male patient with no previous relevant medical history, presented to the ophthalmology clinic in a tertiary hospital. He complained of a sudden drop of vision in his left eye, throbbing left sided headaches, central scotoma, color depth affection, elevated intra-ocular pressure; two weeks post-COVID-19 infection.
RESULTS
RESULTS
Post-COVID optic neuritis is a possible neurological complication of the novel coronavirus infection. It was shown that females were more affected by optic neuritis and retinal complications, the left eye is more liable to drop of visual acuity post-COVID-19 infection; while there was no significant difference between both eyes regarding accompanied vision loss or blindness.
CONCLUSIONS
CONCLUSIONS
Optic neuritis either unilateral or bilateral could be one of the possible viral manifestations after COVID-19 infection.
Identifiants
pubmed: 34312592
doi: 10.1016/j.inat.2021.101320
pii: S2214-7519(21)00232-2
pmc: PMC8295047
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101320Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Gen Intern Med. 2020 May;35(5):1545-1549
pubmed: 32133578
N Engl J Med. 2006 Mar 23;354(12):1273-80
pubmed: 16554529
Ocul Immunol Inflamm. 2020 Aug 17;28(6):922-925
pubmed: 32870739
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Curr Eye Res. 2021 Dec;46(12):1934-1935
pubmed: 33661715
J Neuroophthalmol. 2020 Sep;40(3):398-402
pubmed: 32604245
JAMA Ophthalmol. 2021 Feb 1;139(2):247-249
pubmed: 33331870
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620976018
pubmed: 33238757
Interdiscip Neurosurg. 2021 Sep;25:101132
pubmed: 33654659
J Neuroimmunol. 2005 May;162(1-2):165-72
pubmed: 15833372
Br J Ophthalmol. 2006 May;90(5):551-4
pubmed: 16622084
Ann Neurol. 1997 Mar;41(3):392-8
pubmed: 9066361